Search results
Exploring Exercise-induced Long QT
Author(s):
William Wiradinata
,
Anita Dominique Subali
,
Muhammad Reva Aditya
Added:
6 months ago
Review Article
Author(s):
Vivek Reddy
Added:
3 weeks ago
AF Symposium 2026 - Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss findings from the ADVENT LTO study, evaluating long-term outcomes and atrial fibrillation progression in patients who received ablation with the FARAPULSE Pulsed Field Ablation System compared to thermal ablation.The study tracked AF progression patterns, arrhythmia recurrence rates,…
View more
Author(s):
Samineh Sehatbakhsh
Added:
6 months ago
Navigate the complex landscape of coronary interventions following transcatheter aortic valve replacement with Dr Samineh Sehatbakhsh, addressing critical access challenges in an era of expanding TAVR indications.This essential presentation, part of the Complex Cases track, examines the growing clinical significance of post-TAVR coronary access as procedures expand to younger, lower-risk patients…
View more
Author(s):
Donna H Ryan
Added:
1 year ago
ECO 2024 — Dr Donna H Ryan (Pennington Biomedical Research Center, US) joins us to discuss the first sub-analysis of the landmark SELECT trial (NCT03574597, Novo Nordisk).In this study, investigators looked at long-term weight loss with semaglutide 2.4 mg compared to a placebo among 17,604 participants. In SELECT, at 208 weeks, semaglutide produced clinically significant weight loss compared to…
View more
Author(s):
Yury Malyshev
Added:
2 years ago
AF Symposium 24 — Dr Yury Malyshev (Mount Sinai Hospital, US) joins us to discuss the findings from three studies focusing on the long-term effects of pulsed-field ablation (PFA) on coronary arteries.QuestionsWhat is known currently about the effect of PFA in Coronary Arteries? What is the importance of this topic?What was the study design and cohort?What are the key findings?Who are the take…
View more
Author(s):
David Erlinge
Added:
4 months ago
TCT 2025 - Findings from INFINITY-SWEDEHEART show significant reductions in target vessel failure and treatment benefit after 6 months to two years with the DynamX bioadaptor stent.Prof David Erlinge (Skane University Hospital, SE) joins us to discuss findings from the INFINITY-SWEDEHEART trial, a prospective, multicenter, registry-based randomized clinical trial comparing long-term outcomes of…
View more
Derk Jan ten Harkel
Job title: Paediatric Cardiologist
Author
Phillip Cuculich
Author
Author(s):
Alexis Cutchins, Svetlana Blitshteyn, Rebecca Steinberg
Start date:
May 02, 2024
Postural Orthostatic Tachycardia Syndrome (POTS) is a heterogenous disorder that presents with positional tachycardia, amongst many other symptoms. Evidence for treatment options remains limited, and there are a multitude of associated conditions with overlapping symptoms which can make the diagnosis and management of POTS a difficult experience for providers and patients alike.This broadcast…
View more
Author(s):
Sukriti Banthiya
,
Medhat Chowdhury
,
Harshil Patel
,
et al
Added:
2 years ago